Virna Marin

1.4k total citations
26 papers, 1.1k citations indexed

About

Virna Marin is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Virna Marin has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Immunology and 10 papers in Genetics. Recurrent topics in Virna Marin's work include CAR-T cell therapy research (23 papers), Immune Cell Function and Interaction (16 papers) and Virus-based gene therapy research (10 papers). Virna Marin is often cited by papers focused on CAR-T cell therapy research (23 papers), Immune Cell Function and Interaction (16 papers) and Virus-based gene therapy research (10 papers). Virna Marin collaborates with scholars based in Italy, United Kingdom and France. Virna Marin's co-authors include Andrea Biondi, Irene Pizzitola, Ettore Biagi, Martin Pulé, Brian Philip, Greta Maria Paola Giordano Attianese, Sarah Tettamanti, Elisabetta Cribioli, Giovanna D’Amico and E. Biagi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and BioEssays.

In The Last Decade

Virna Marin

25 papers receiving 1.1k citations

Peers

Virna Marin

ONCOL

IMMUN

GENET

Sarah Tettamanti Italy

Hiroki Torikai United States

Anthony F. Daniyan United States

Nicoletta Cieri Italy

Brock Lanier United States

Diogo Gomes‐Silva United States

Farzana Nazimuddin United States

Peihua Lu China

Maria‐Luisa Schubert Germany

Brandon Ballard United States

Sarah Tettamanti Italy

Virna Marin

947 ×1.0

ONCOL

536 ×1.0

IMMUN

358 ×1.0

GENET

406 ×1.2

197 ×0.9

Citations per year, relative to Virna Marin Virna Marin (= 1×) peers Sarah Tettamanti

Countries citing papers authored by Virna Marin

Since Specialization

Citations

This map shows the geographic impact of Virna Marin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virna Marin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virna Marin more than expected).

Fields of papers citing papers by Virna Marin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virna Marin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virna Marin. The network helps show where Virna Marin may publish in the future.

Co-authorship network of co-authors of Virna Marin

This figure shows the co-authorship network connecting the top 25 collaborators of Virna Marin. A scholar is included among the top collaborators of Virna Marin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virna Marin. Virna Marin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Addio, Francesca, Laura Montefusco, Maria Elena Lunati, et al.. (2023). Targeting a novel apoptotic pathway in human disease. BioEssays. 45(6). e2200231–e2200231. 4 indexed citations

Piovan, Claudia, Virna Marin, Cinzia Scavullo, et al.. (2017). Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes. Molecular Therapy — Methods & Clinical Development. 5. 22–30. 16 indexed citations

Marin, Virna, Anna Stornaiuolo, Claudia Piovan, et al.. (2016). RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope. Molecular Therapy — Methods & Clinical Development. 3. 16033–16033. 18 indexed citations

Tettamanti, Sarah, Virna Marin, Irene Pizzitola, et al.. (2013). Targeting of acute myeloid leukaemia by cytokine‐induced killer cells redirected with a novel CD123‐specific chimeric antigen receptor. British Journal of Haematology. 161(3). 389–401. 175 indexed citations

Laurin, David, Virna Marin, Ettore Biagi, et al.. (2013). Upregulation of Adhesion Molecules on Leukemia Targets Improves the Efficacy of Cytotoxic T Cells Transduced With Chimeric Anti-CD19 Receptor. Journal of Immunotherapy. 36(3). 181–189. 9 indexed citations

Marin, Virna, Elisabetta Cribioli, Brian Philip, et al.. (2012). Comparison of Different Suicide-Gene Strategies for the Safety Improvement of Genetically Manipulated T Cells. Human Gene Therapy Methods. 23(6). 376–386. 106 indexed citations

Tettamanti, Sarah, Virna Marin, Irene Pizzitola, et al.. (2012). Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor.. Blood. 120(21). 3010–3010. 5 indexed citations

Dutour, Aurélie, Virna Marin, Irene Pizzitola, et al.. (2012). In VitroandIn VivoAntitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL againstCD33+Acute Myeloid Leukemia. Advances in Hematology. 2012. 1–10. 84 indexed citations

Pizzitola, Irene, Valentina Agostoni, Elisabetta Cribioli, et al.. (2011). In Vitro Comparison of Three Different Chimeric Receptor-modified Effector T-cell Populations for Leukemia Cell Therapy. Journal of Immunotherapy. 34(6). 469–479. 15 indexed citations

10.

Biagi, Ettore, Virna Marin, Greta Maria Paola Giordano Attianese, et al.. (2011). New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future. The Italian Journal of Pediatrics/Italian journal of pediatrics. 37(1). 46–46. 9 indexed citations

11.

Attianese, Greta Maria Paola Giordano, Virna Marin, Valentina Hoyos, et al.. (2011). In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor. Blood. 117(18). 4736–4745. 67 indexed citations

12.

Marin, Virna, Irene Pizzitola, Valentina Agostoni, et al.. (2010). Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors. Haematologica. 95(12). 2144–2152. 107 indexed citations

13.

Laurin, David, Virna Marin, Ettore Biagi, et al.. (2010). Exploration of the Lysis Mechanisms of Leukaemic Blasts by Chimaeric T-Cells. SHILAP Revista de lepidopterología. 2010. 1–9. 8 indexed citations

14.

Dander, Erica, Giuseppina Li Pira, Ettore Biagi, et al.. (2008). Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library. Experimental Hematology. 36(4). 473–485. 5 indexed citations

15.

Attianese, Greta Maria Paola Giordano, Valentina Hoyos, Barbara Savoldo, et al.. (2008). Generation of a New Chimeric Antigen Receptor (CAR) to Target CD23 Expressed on Chronic Lymphocytic Leukemia (B-CLL) Cells. Blood. 112(11). 3538–3538. 2 indexed citations

16.

Biagi, E., Virna Marin, Greta Maria Paola Giordano Attianese, et al.. (2007). Chimeric T-cell receptors: new challenges for targeted immunotherapy in hematologic malignancies. Haematologica. 92(3). 381–388. 27 indexed citations

17.

Marin, Virna, Harumi Kakuda, Erica Dander, et al.. (2007). Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-ζ activating signal. Experimental Hematology. 35(9). 1388–1397. 45 indexed citations

18.

Marin, Virna, Erica Dander, Ettore Biagi, et al.. (2006). Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy. Experimental Hematology. 34(9). 1218–1228. 63 indexed citations

19.

D’Amico, Giovanna, Martín Bonamino, Erica Dander, et al.. (2006). T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy. Leukemia. 20(11). 2015–2024. 15 indexed citations

20.

D’Amico, Giovanna, Virna Marin, Andrea Biondi, & Martín Bonamino. (2004). Potential use of CD40 ligand for immunotherapy of childhood B-cell precursor acute lymphoblastic leukaemia. Best Practice & Research Clinical Haematology. 17(3). 465–477. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact